Obesity

About the conference

Conferences serve as a vital platform for academic researchers, industry professionals, and business leaders to engage, collaborate, and exchange knowledge. These events feature insightful keynote presentations, interactive breakout sessions, hands-on demonstrations, and unparalleled networking opportunities. We are proud to host an outstanding lineup of world-renowned speakers, thought leaders, brand ambassadors, and subject matter experts who will share their perspectives with our attendees.

We are delighted to invite you to join us at the Global Summit on Obesity 2025, taking place in the vibrant city of Dubai, UAE, on October 20–21, 2025, under the theme: “Shaping a Healthier Future: Advances in Obesity Research and Care.” This premier event will bring together leading scholars, researchers, scientists, professors, postdoctoral fellows, and academic professionals to present their work and explore cutting-edge developments in obesity and nutritional health.

Global Summit on Obesity 2025 offers an exceptional platform for global networking, uniting distinguished experts, educators, and students from around the world. This exciting and memorable scientific gathering will showcase the latest advancements in obesity research, therapeutic innovations, and wellness strategies. It also provides an excellent opportunity for participants from universities and institutions to engage directly with world-class speakers and foster collaborations aimed at advancing treatments and improving public health outcomes.

Why to attend

Achieve your professional objectives by connecting with global experts in the field of obesity.

This event offers a unique and valuable opportunity to engage with a diverse audience from leading research institutions, universities, clinics, and hospitals. It is one of the most comprehensive gatherings of professionals dedicated to obesity research, treatment, and prevention.

Showcase your work, share valuable data, conduct live demonstrations, connect with potential collaborators, and promote your innovations—all while gaining enhanced visibility and recognition at this impactful 2-day conference.

Featuring world-renowned speakers, cutting-edge techniques, the latest advancements in obesity research, and thought-provoking discussions, this conference promises to be a landmark event in the field.

Sessions and tracks

Track 1: Obesity & Metabolic Disorders

Obesity is a multifactorial condition characterized by excessive body fat, posing significant risks for chronic diseases such as cardiovascular disorders, diabetes, hypertension, and certain cancers. It often results from a combination of excessive caloric intake and insufficient physical activity. Metabolic syndrome, closely associated with obesity, involves a cluster of conditions—including insulin resistance, elevated blood pressure, dyslipidemia, and hyperglycemia—that increase the risk of heart disease and type 2 diabetes. Diagnosis typically involves assessing blood pressure, glucose levels, cholesterol, and triglycerides.

Track 2: Bariatric Surgery and Its Types

Bariatric surgery encompasses various procedures aimed at treating obesity by reducing stomach capacity (restriction) and nutrient absorption (malabsorption). These surgeries are effective in promoting weight loss and reducing obesity-related complications. Common types include:

• Gastric bypass

• Laparoscopic adjustable gastric banding

• Sleeve gastrectomy

• Biliopancreatic diversion with duodenal switch
  Bariatric surgery can also enhance fertility outcomes in obese women and improve reproductive health.

Track 3: Obesity and Nutrition

Inadequate nutrition and sedentary lifestyles are major contributors to obesity. A diet rich in sodium, added sugars, and low in essential micronutrients can increase the risk of chronic diseases. Nutritional deficiencies—especially in vitamins A, D, B-complex, and minerals such as calcium and magnesium—are often seen in individuals with high BMI. Nutritional management for obese individuals involves careful monitoring of electrolytes and adopting a balanced, nutrient-dense diet alongside physical activity.

Track 4: Endocrinal and Hormonal Obesity

Hormones such as insulin, leptin, growth hormone, and sex hormones play a critical role in appetite regulation, metabolism, and fat distribution. Hormonal imbalances contribute significantly to obesity and are linked with endocrine disorders such as hypothyroidism, PCOS, Cushing’s syndrome, and hypothalamic dysfunction. Endocrinologists can aid in diagnosing and treating these conditions, often integrating pharmacological interventions and lifestyle strategies for weight management.

Track 5: Obesity and Pregnancy: Risks and Management

Maternal obesity is associated with a higher risk of complications during pregnancy, including miscarriage, gestational diabetes, hypertension, preeclampsia, and birth defects. Management strategies include tailored dietary plans, regular physical activity, and behavioral interventions to avoid excessive gestational weight gain. Proper prenatal care and collaboration with dietitians are essential to support both maternal and fetal health.

Track 6: Obesity and Cardiovascular Diseases

Excess body weight increases the workload on the heart, leading to elevated blood pressure and higher risk of heart attack, stroke, and heart failure. Obesity also alters lipid profiles and contributes to atherosclerosis. Risk factors such as poor diet, low physical activity, and genetic predispositions compound these effects. Early intervention with lifestyle modification can significantly reduce cardiovascular risks.

Track 7: Obesity and Diabetes

There is a strong correlation between obesity and type 2 diabetes. Obesity contributes to insulin resistance, impairing glucose metabolism and increasing blood sugar levels. Diets high in saturated fats, refined carbohydrates, and added sugars further exacerbate the condition. Lifestyle modification, including healthy eating, physical activity, and stress management, plays a key role in diabetes prevention and control.

Track 8: Obesity and Cancer

Obesity has been identified as a risk factor for various cancers, including breast, colon, endometrial, prostate, and kidney cancer. Excess body fat can cause chronic inflammation, hormonal imbalances, and insulin resistance, all of which may contribute to carcinogenesis. Dietary habits and sedentary behavior also play a role in increasing cancer susceptibility in obese individuals.

Track 9: Obesity and Depression

A growing body of evidence links obesity with mood disorders such as depression and anxiety. Inflammatory pathways, hormonal changes, and social stigma may contribute to this association. Studies show that individuals with obesity have a higher risk of developing depression and related mental health conditions. Addressing both mental and physical health is essential in obesity management strategies.

Track 10: Anti-obesity Drugs

Pharmacological agents for weight management aim to reduce appetite or decrease nutrient absorption. These include:

• Appetite suppressants

• Fat absorption inhibitors
  While lifestyle interventions remain the cornerstone of obesity treatment, medications may be prescribed for patients who struggle with weight loss through diet and exercise alone. Long-term safety and effectiveness remain critical considerations.

Track 11: Childhood Obesity

Childhood obesity has reached alarming levels globally, with long-term health consequences including type 2 diabetes, cardiovascular diseases, orthopedic issues, and psychological challenges. Risk factors include poor diet, low physical activity, genetics, and limited health education. Early intervention through structured nutrition programs, sports, and school-based initiatives is crucial.

Track 12: Advanced Treatment for Obesity

Advanced obesity management combines lifestyle interventions with medical and surgical therapies. These include:

• Ketogenic and protein-rich diets

• Clinical protocols for morbid obesity

• Non-invasive inch loss therapies

• Combination therapies (diet, drugs, surgery)
  Regular BMI monitoring and individualized treatment plans are essential for effective weight management.

Track 13: Current Research on Obesity and Diet

Emerging research highlights the complex interplay between diet, genetics, metabolism, and chronic disease. High BMI is linked to increased risks for cardiovascular diseases, diabetes, and certain cancers. Dietary patterns high in processed meats and refined sugars elevate these risks, while diets rich in whole grains, fruits, and vegetables promote better outcomes. Research continues to explore sustainable diet strategies and public health interventions.

Track 14: Role of Steroids and Hormones in Obesity

Hormones like glucocorticoids and sex hormones influence metabolic and neurological pathways, impacting both weight and cognitive function. Chronic stress and hormonal imbalances can contribute to obesity and neurodegeneration. Research in this area explores the regulatory roles of these hormones in inflammation, metabolic syndrome, and brain health, offering insight into targeted therapeutic interventions.

Track 15: Obesity in Animals

Obesity in animals, especially pets, is defined by excess fat accumulation and is commonly assessed using the Body Condition Score (BCS). Factors contributing to animal obesity include overfeeding, inactivity, and hormonal disorders. While not as precise as advanced imaging like DEXA, BCS is a practical, non-invasive tool for clinical assessments. Addressing obesity in animals involves dietary management, exercise, and owner education.

Target Audience

1. Endocrinologists & Obesity Specialists

2. Bariatric Surgeons & Gastroenterologists

3. Nutritionists & Dietitians

4. Public Health Officials & Policymakers

5. Pharmaceutical & Biotech Researchers

6. Digital Health & Wellness Tech Companies

7. Academic Researchers & Epidemiologists

8. Pediatricians & Child Health Experts

9. Mental Health Professionals

10. Healthcare Providers & Primary Care Physicians

Market analysis

Global Obesity Market Overview

Obesity has become a global health crisis, driving an unprecedented surge in demand for treatment, technology, and policy innovation. The Global Obesity Market is expanding across several verticals, including pharmacology, digital health, behavioral therapy, and clinical interventions.

Key Market Drivers:

• Increasing global obesity prevalence
• Rise in chronic diseases like type 2 diabetes & cardiovascular disorders
• Innovations in GLP-1-based and hormone therapies
• Growth of AI-driven health monitoring & digital therapeutics
• Government and institutional awareness campaigns

Conclusion

The Global Obesity Summit 2025 arrives at a pivotal time as the global market transitions from traditional weight-loss models to an integrated, innovation-driven ecosystem. The summit offers unmatched value as a platform to:

• Showcase next-gen research & therapies
• Launch new solutions and trials
• Foster academic, clinical, and commercial partnerships
• Shape the global response to the obesity epidemic

 Make GOS-2025 a hub for science, strategy, and solution-building in the fight against obesity.